Griseofulvin (Rising Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Griseofulvin drug offered from Rising Pharmaceuticals Inc.. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rising Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Griseofulvin |
| SUBSTANCE NAME: | GRISEOFULVIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-12-06 |
| END MARKETING DATE: | 0000-00-00 |
Griseofulvin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Griseofulvin from Rising Pharmaceuticals Inc. |
| LABELER NAME: | Rising Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2012-12-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64980-186_7a7e6024-fcb1-4e9a-8de4-30d7c97210c0 |
| PRODUCT NDC: | 64980-186 |
| APPLICATION NUMBER: | ANDA202482 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:
